Back
Context Therapeutics Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
10
CNTX
Context Therapeutics
Last Price:
1.46
Seasonality Move:
-30%
Sell
30
COLL
Collegium Pharmaceutical
Last Price:
30.92
Seasonality Move:
19.53%
Sell
10
Context Therapeutics (CNTX)
is a Sell
Is Context Therapeutics a Buy, Sell or Hold?
- The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- CNTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $29.96. The Score for COLL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- COLL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNTX Stock Price Chart
What is Context Therapeutics's stock price today?
-
The Context Therapeutics share price today is $1.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $29.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.
CNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 23.23 | Sell |
| Chaikin Money Flow: | 392487 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.75 - 2.29) | Sell |
| Bollinger Bands (100): | (1.89 - 2.39) | Sell |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.75 | Sell |
| Relative Strength Index (14 RSI): | 33.15 | Sell |
| Chaikin Money Flow: | -262078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.5 - 35.14) | Sell |
| Bollinger Bands (100): | (32.57 - 38.29) | Sell |
CNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 1.83 | Sell |
| 8-day EMA: | 1.66 | Sell |
| 20-day EMA: | 1.86 | Sell |
| 50-day EMA: | 2 | Sell |
| 200-day EMA: | 1.85 | Sell |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.92 | Buy |
| 20-day SMA: | 32.15 | Sell |
| 50-day SMA: | 35.66 | Sell |
| 200-day SMA: | 35.36 | Sell |
| 8-day EMA: | 30.37 | Sell |
| 20-day EMA: | 31.98 | Sell |
| 50-day EMA: | 34.15 | Sell |
| 200-day EMA: | 33.95 | Sell |
Context Therapeutics Earnings Growth & CNTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.21 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.42 per share.
Context Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||